US opioid overdose deaths fall overall but disparities rise for seniors and minorities

A study of 800,645 overdose deaths in the United States shows the national rate peaked at 33.24 per 100,000 in August 2023 and then declined for 15 months, reaching 24.29 per 100,000 in October 2024 – a drop of about 27%. The decline was driven mainly by reductions in opioid‑related deaths, especially fentanyl, while deaths involving stimulants such as cocaine and methamphetamine fell more slowly.

The improvement was uneven. The Northeast, Midwest and South saw earlier peaks and declines, whereas the West peaked a year later. Demographically, deaths continued to rise among adults 55 years and older and among American Indian or Alaska Native, Black, Hispanic and multiracial groups, even though the upward trend slowed.

In parallel, experts have issued new hospital‑based treatment guidelines for opioid use disorder. Using a Delphi consensus of 42 clinicians, the recommendations stress initiating medications such as methadone or buprenorphine during hospitalization rather than waiting for discharge. The guidelines cite the surge of high‑potency synthetic opioids like fentanyl, which are cheap to produce and increasingly mixed into other substances, raising overdose risk.